Latest News from NPR

on:

NCPR is supported by:

 
Hourly Newscast
4 min., 45 sec.

Programs

Latest program rundown

Coming up:

Latest Features:
April 23, 2014 | NPR · They say they were placed on the list for refusing to inform on other Muslims. The suit is part of a broad wave of cases challenging the secretive no-fly list and U.S. counterterrorism strategies.
 
Courtesy of Sertoma Centre
April 23, 2014 | NPR · Activists say a federal law that allows employers to pay people with disabilities pennies per hour is out of date and should be changed. But some say the law is a lifeline for the disabled.
 
AP
April 23, 2014 | NPR · Shakespeare's Globe Theater aims to take the Bard's iconic play to every country in the world. It will perform everywhere from prestigious theaters to Pacific island beaches.
 

Latest program rundown

Coming up:

Latest Features:
April 21, 2014 | NPR · Last year a scientist said he'd found a new form of botulinum toxin, and was keeping details secret to keep the recipe from terrorists. But other science and public health labs were shut out, too.
 
April 23, 2014 | NPR · Pharmaceutical companies are suddenly trading entire divisions the way sports teams swap players. Glaxo, Novartis and Ely Lily are all involved in a complicated deal announced Tuesday, and so far this year, five deals exceeding $2 billion have been announced. What's driving the deal-making?
 
Barcroft Media/Landov
April 23, 2014 | NPR · For decades, a mysterious quacking "bio-duck" has been heard roaming the waters of the Southern Ocean. Now scientists say the source is a whale.
 

Latest Saturday rundown




WE Saturday Feature

April 19, 2014 | NPR · The search continues for hundreds of people, mostly students, who were on board a South Korean ferry when it sank this week. Correspondent Anthony Kuhn shares the latest with NPR's Wade Goodwyn.
 

Latest Sunday rundown


WE Sunday Feature

April 20, 2014 | NPR · Monday is the 2014 Boston Marathon. Security will be tight, and this year's race will be an emotional event that will be about more than who wins.
 

Latest program rundown

Coming up:

Pharmaceuticals

Apr 23, 2014 — Sovaldi has been found to be remarkably effective in curing most patients with common forms of hepatitis C in a matter of months. But the clinical success comes at a high price.
Comments |
Apr 8, 2014 — New drugs are usually tested in animals before they're tested in humans. But many of those studies aren't done carefully enough, analysts say. So time and money is wasted, and treatments are delayed.
Launch in player | Comments |
Apr 3, 2014 — Allergy shots work, but they're inconvenient and painful. Now there are pills that can help people tolerate grass pollen. But allergies are rarely limited to grass alone.
Comments |
Mar 31, 2014 — As infectious diseases come under control in Africa, other illnesses common in the West are becoming problems. GlaxoSmithKline is opening a research lab to promote research by African scientists.
Comments |
Mar 30, 2014 — Medicine's shift from paper to computers has been painful and expensive. But now doctors can easily write and transmit prescriptions by computer, saving money and improving the quality of care.
Comments |
Mar 26, 2014 — The bottles that appear to have been tampered with contained tablets and capsules in various shapes and colors, rather than the turquoise capsule used for the over-the-counter medication alli.
Comments |
Mar 20, 2014 — New advice to reduce heart attacks and strokes could more than double the number of Americans taking cholesterol-lowering statins to 56 million. The expansion could cost as much as $7 billion a year.
Comments |
Mar 12, 2014 — Private insurers, as well as those serving Medicaid patients, are wrestling with how to cover the new drugs. Many say they will require prior approval and may be limited to the sickest patients.
Comments |
Mar 4, 2014 — The sharp decline in payments coincides with increased scrutiny of drug marketing. Later this year, federal law will also require that drugmakers disclose the amount of money they give to doctors.
Launch in player | Comments |
Feb 21, 2014 — The Food and Drug Administration says the long list of side effects read rapidly at the end of pharmaceutical ads may be too much for people to grasp. The agency is looking at a streamlined approach.
Comments |
more Pharmaceuticals from NPR